U.S. Faces Scrutiny Over Measles Elimination Status
An international review of the U.S.'s measles elimination status is postponed to November by the Pan American Health Organization. The delay is to allow more time for data analysis amid ongoing outbreaks, primarily in South Carolina. U.S. officials are advocating for vaccination as a critical preventive measure.
An international panel meeting to review the United States' measles elimination status has been delayed to November, announced the Pan American Health Organization on Monday. This postponement comes at the request of U.S. health officials to provide additional time for data analysis concerning the measles outbreaks.
The assessment by PAHO will address whether the ongoing measles spread, originating from a Texas outbreak in January last year, could impact the U.S.'s elimination status. Since 2000, the U.S. has maintained this status, signifying no continuous transmission for over a year.
Under Health Secretary Robert F. Kennedy Jr., the spread continued with over 1,000 cases in 2026, predominantly in South Carolina. Despite misinformation regarding vaccine safety, health authorities emphasize the measles vaccine as vital protection. CDC's acting director, Jay Bhattacharya, encouraged vaccinations and offered increased federal support.
ALSO READ
-
US Measles Elimination Status Review Postponed
-
Nominee Advocates for Vaccines Amid Rising Measles Cases
-
EXCLUSIVE-South Carolina seeks non-CDC reinforcements to contain growing measles outbreak
-
US Domestic News Roundup: Measles, Redistricting, and Political Feuds
-
Surge in Measles Cases Highlights Vaccination Debate